Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 397 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Young-onset colorectal cancer in New South Wales: a population-based studyBoyce, S.; Nassar, N.; Lee, C.; Suen, M.; Zahrani, S.; Gladman, M.
2018A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorderStacey, D.; Schubert, K.; Clark, S.; Amare, A.; Milanesi, E.; Maj, C.; Lechband, S.; Shekhtman, T.; Kelsoe, J.; Gurwitz, D.; Baune, B.
2011Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous AustraliansDavis, J.; Cheng, A.; Mcmillan, M.; Humphrey, A.; Stephens, D.; Anstey, N.
2012Carbon dioxide insufflation during colonoscopy in deeply sedated patientsSingh, R.; Neo, E.; Nordeen, N.; Shanmuganathan, G.; Ashby, A.; Drummond, S.; Nind, G.; Murphy, E.; Luck, A.; Tucker, G.; Tan, W.
2012N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyThakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Liew, D.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2019Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) studyLioufas, N.; Toussaint, N.D.; Pedagogos, E.; Elder, G.; Badve, S.V.; Pascoe, E.; Valks, A.; Hawley, C.; Block, G.A.; Boudville, N.C.; Campbell, K.; Cameron, J.D.; Chen, S.S.M.; Faull, R.J.; Holt, S.G.; Hooi, L.S.; Jackson, D.; Jardine, M.J.; Johnson, D.W.; Kerr, P.G.; et al.
2015Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination usersNielsen, S.; Hillhouse, M.; Mooney, L.; Ang, A.; Ling, W.
2018High baseline levels of tumor necrosis factor receptor 1 are associated with progression of kidney disease in Indigenous Australians with diabetes: the eGFR follow-up studyBarr, E.L.; Barzi, F.; Hughes, J.T.; Jerums, G.; Hoy, W.E.; O'Dea, K.; Jones, G.R.; Lawton, P.D.; Brown, A.D.; Thomas, M.; Ekinci, E.I.; Sinha, A.; Cass, A.; MacIsaac, R.J.; Maple-Brown, L.J.
2017Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adultsAmarasekera, A.; Assadi-Khansari, B.; Liu, S.; Black, M.; Dymmott, G.; Rogers, N.; Sverdlov, A.; Horowitz, J.; Ngo, D.; Roberts, D.
2017A latent genetic subtype of major depression identified by whole-exome genotyping data in a Mexican-American cohortYu, C.; Arcos-Burgos, M.; Licinio, J.; Wong, M.